These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12223076)

  • 1. Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.
    Ge Z
    Expert Opin Ther Targets; 2002 Apr; 6(2):135-46. PubMed ID: 12223076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and functional characterization of Helicobacter pylori fumarate reductase operon comprising three structural genes coding for subunits C, A and B.
    Ge Z; Jiang Q; Kalisiak MS; Taylor DE
    Gene; 1997 Dec; 204(1-2):227-34. PubMed ID: 9434188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach.
    Ge Z; Feng Y; Dangler CA; Xu S; Taylor NS; Fox JG
    Microb Pathog; 2000 Nov; 29(5):279-87. PubMed ID: 11031122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumarate reductase of Helicobacter pylori--an immunogenic protein.
    Birkholz S; Knipp U; Lemma E; Kröger A; Opferkuch W
    J Med Microbiol; 1994 Jul; 41(1):56-62. PubMed ID: 8006945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials.
    Ohishi T; Inaoka DK; Kita K; Kawada M
    Chem Pharm Bull (Tokyo); 2018; 66(3):239-242. PubMed ID: 29491257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumarate reductase: a target for therapeutic intervention against Helicobacter pylori.
    Mendz GL; Hazell SL; Srinivasan S
    Arch Biochem Biophys; 1995 Aug; 321(1):153-9. PubMed ID: 7639515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel therapeutic targets in Helicobacter pylori.
    Loughlin MF
    Expert Opin Ther Targets; 2003 Dec; 7(6):725-35. PubMed ID: 14640908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives.
    Axon AT
    Gut; 1998 Jul; 43 Suppl 1(Suppl 1):S70-3. PubMed ID: 9764045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-microbial and anti-inflammatory effects of Cheonwangbosim-dan against
    Park HS; Jeong HY; Kim YS; Seo CS; Ha H; Kwon HJ
    J Vet Sci; 2020 May; 21(3):e39. PubMed ID: 32476313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies for the prevention and treatment of Helicobacter pylori infection.
    Ruggiero P; Peppoloni S; Berti D; Rappuoli R; Giudice GD
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1127-38. PubMed ID: 12150706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Helicobacter pylori infection. Whom to treat and with what?].
    Dehesa-Violante M
    Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):50-5. PubMed ID: 11464622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis.
    Ottlecz A; Romero JJ; Lichtenberger LM
    Aliment Pharmacol Ther; 1999 Jul; 13(7):875-81. PubMed ID: 10383521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M; Figura N
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
    Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of
    Lahner E; Carabotti M; Annibale B
    World J Gastroenterol; 2018 Jun; 24(22):2373-2380. PubMed ID: 29904244
    [No Abstract]   [Full Text] [Related]  

  • 20. Clarithromycin for Helicobacter pylori infection.
    Leung WK; Graham DY
    Expert Opin Pharmacother; 2000 Mar; 1(3):507-14. PubMed ID: 11249534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.